Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgical Innovations GroupLSE:SUN EV-to-FCF is 13.20 as of Jul. 21, 2026, which is 28% above its 10-year median of 10.31. The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Surgical Innovations Group ranks better than 75.6% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Surgical Innovations Group's Enterprise Value is £4.52 Mil.
Surgical Innovations Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £0.34 Mil. Therefore, Surgical Innovations Group's EV-to-FCF for today is 13.20.
The historical rank and industry rank for Surgical Innovations Group's EV-to-FCF or its related term are showing as below:
LSE:SUN'
s EV-to-FCF Range Over the Past 10 Years
Min: -35.51 Med: 10.31 Max: 267.44
Current: 13.2
During the past 13 years, the highest EV-to-FCF of Surgical Innovations Group was 267.44. The lowest was -35.51. And the median was 10.31.
LSE:SUN's EV-to-FCF is ranked better than 75.6% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.21
vs LSE:SUN: 13.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Surgical Innovations Group (LSE:SUN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Surgical Innovations Group's PE Ratio (TTM) for today is calculated as:
Surgical Innovations Group's share price for today is £0.005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Surgical Innovations Group EV-to-FCF Related Terms
Surgical Innovations Group EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surgical Innovations Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's EV-to-FCF falls into.
Surgical Innovations Group's current Enterprise Value is £4.52 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £0.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a EV-to-FCF of 13.20 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Surgical Innovations Group and its competitors. This is 28% above median its historical median of 10.31. According to the industry distribution chart, Surgical Innovations Group ranks #101 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 24.4%.
Is Surgical Innovations Group's EV-to-FCF too high?
Surgical Innovations Group's current EV-to-FCF of 13.20 is 28% above median its 10-year median of 10.31. The Medical Devices & Instruments industry median EV-to-FCF is 23.21. Surgical Innovations Group's value of 13.20 is 43.1% below this industry median. Based on the distribution chart, Surgical Innovations Group ranks #101 out of 414 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Surgical Innovations Group's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #101 out of 414 companies for EV-to-FCF. This places Surgical Innovations Group in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.21. Surgical Innovations Group's value of 13.20 is 43.1% below this benchmark. While the company's 10-year median is 10.31 vs. the industry median of 23.21, Surgical Innovations Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.21, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current EV-to-FCF of 13.20 is 43.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current EV-to-FCF is 13.20, which is 28% above median its own 10-year median of 10.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.01 — trading 50% below its estimated fair value. The current EV-to-FCF is 13.20, which is 28% above median its 10-year median of 10.31 and 43.1% below the Medical Devices & Instruments industry median of 23.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current EV-to-FCF is 13.20 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 
